secwatch.observer — SEC 8-K summary
======================================

Issuer:     MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI)
CIK:        0001823239
Form:       8-K
Filed at:   2022-10-03T23:59:59+00:00
Accession:  0001823239-22-000048
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Maravai names Trey Martin CEO, co-founder Carl Hull becomes Executive Chairman
------------------------------------------------------------------------------

- Martin appointed CEO effective Sept 30, 2022, succeeding Carl Hull who becomes Executive Chairman.
- Martin previously SVP at Danaher, President of Integrated DNA Technologies; over 25 yrs in life sciences.
- Martin receives base salary $750k, target bonus $937.5k for 2022, and equity awards totaling ~$17M.
- Hull's base salary reduced to $500k; target bonus for 2022 remains $725k, subsequent years 100% of base.
- Company to discuss transition on Q3 2022 earnings call scheduled for Nov 2.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/0001823239-22-000048-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1823239/000182323922000048/mrvi-20220930.htm
  HTML page:      https://secwatch.observer/filing/0001823239-22-000048

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer